Search research articles
Contact Us
Filters
Showing results (41-50 of 49) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 49 results.
Inflammatory Bowel Diseases
|
September 23, 2020
Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis of Results from Phase 2/3 Studies
William J Sandborn, Brian G Feagan, Silvio Danese, et al.
The Lancet. Gastroenterology & Hepatology
|
January 16, 2026
Efficacy and safety of subcutaneous guselkumab induction therapy in participants with moderately to severely active ulcerative colitis (ASTRO): a double-blind, treat-through, randomised, placebo-controlled, phase 3 trial
Millie Long, Jessica R Allegretti, Silvio Danese, et al.
Pharmaceutics
|
September 28, 2023
Preclinical Investigation of a Lipoglycopeptide Dry Powder Inhalation Therapy for the Treatment of Pulmonary MRSA Infection
Donna M Konicek, Adam J Plaunt, Sachin Gharse, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 8, 2025
Functional Brain Age Acceleration from Dynamic and Static Connectivity Predicts Working Memory and Attention Deficits in Schizophrenia
Sabrina J Edwards-Swart, Bradley Thomas Baker, Daniel H Mathalon, et al.
Frontiers in Robotics and AI
|
March 21, 2022
Exodex Adam-A Reconfigurable Dexterous Haptic User Interface for the Whole Hand
Neal Y Lii, Aaron Pereira, Julian Dietl, et al.
International Journal of Molecular Sciences
|
January 12, 2021
Development and Characterization of Treprostinil Palmitil Inhalation Aerosol for the Investigational Treatment of Pulmonary Arterial Hypertension
Adam J Plaunt, Sadikul Islam, Tony Macaluso, et al.
Journal of Crohn'S & Colitis
|
March 20, 2023
A Phase 2b, Randomised, Double-blind, Placebo-controlled, Parallel-arm, Multicenter Study Evaluating the Safety and Efficacy of Tesnatilimab in Patients with Moderately to Severely Active Crohn's Disease
Matthieu Allez, Bruce E Sands, Brian G Feagan, et al.
Inflammatory Bowel Diseases
|
September 19, 2025
Ustekinumab Intravenous Reinduction after Secondary Loss of Response in Patients with Crohn's Disease
Stefan Schreiber, Scott D Lee, C Janneke van der Woude, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
May 29, 2019
Crosslinker Copolymerization for Property Control in Inverse Vulcanization
Jessica A Smith, Sarah J Green, Samuel Petcher, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 49) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 49 results.
Inflammatory Bowel Diseases
|
September 23, 2020
Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis of Results from Phase 2/3 Studies
William J Sandborn, Brian G Feagan, Silvio Danese, et al.
The Lancet. Gastroenterology & Hepatology
|
January 16, 2026
Efficacy and safety of subcutaneous guselkumab induction therapy in participants with moderately to severely active ulcerative colitis (ASTRO): a double-blind, treat-through, randomised, placebo-controlled, phase 3 trial
Millie Long, Jessica R Allegretti, Silvio Danese, et al.
Pharmaceutics
|
September 28, 2023
Preclinical Investigation of a Lipoglycopeptide Dry Powder Inhalation Therapy for the Treatment of Pulmonary MRSA Infection
Donna M Konicek, Adam J Plaunt, Sachin Gharse, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 8, 2025
Functional Brain Age Acceleration from Dynamic and Static Connectivity Predicts Working Memory and Attention Deficits in Schizophrenia
Sabrina J Edwards-Swart, Bradley Thomas Baker, Daniel H Mathalon, et al.
Frontiers in Robotics and AI
|
March 21, 2022
Exodex Adam-A Reconfigurable Dexterous Haptic User Interface for the Whole Hand
Neal Y Lii, Aaron Pereira, Julian Dietl, et al.
International Journal of Molecular Sciences
|
January 12, 2021
Development and Characterization of Treprostinil Palmitil Inhalation Aerosol for the Investigational Treatment of Pulmonary Arterial Hypertension
Adam J Plaunt, Sadikul Islam, Tony Macaluso, et al.
Journal of Crohn'S & Colitis
|
March 20, 2023
A Phase 2b, Randomised, Double-blind, Placebo-controlled, Parallel-arm, Multicenter Study Evaluating the Safety and Efficacy of Tesnatilimab in Patients with Moderately to Severely Active Crohn's Disease
Matthieu Allez, Bruce E Sands, Brian G Feagan, et al.
Inflammatory Bowel Diseases
|
September 19, 2025
Ustekinumab Intravenous Reinduction after Secondary Loss of Response in Patients with Crohn's Disease
Stefan Schreiber, Scott D Lee, C Janneke van der Woude, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
May 29, 2019
Crosslinker Copolymerization for Property Control in Inverse Vulcanization
Jessica A Smith, Sarah J Green, Samuel Petcher, et al.
Page
of 5